OCBCO
UTHR icon

Oversea-Chinese Banking Corp (OCBC)’s United Therapeutics UTHR Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,200
Closed -$382K – 429
2024
Q2 		$382K Buy
+1,200
New +$318K 0.01% 301

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s UTHR Position: Q3 2024 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of United Therapeutics (UTHR) in Q3 2024, closing a stake of 1,200 shares — an estimated $382K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in UTHR in Q2 2024 and held it in 1 quarter. The position peaked at $382K in Q2 2024. 624 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining United Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 1,200 United Therapeutics shares in Q3 2024, an estimated $382K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in United Therapeutics in Q2 2024 and held it in 1 quarter.
  • Oversea-Chinese Banking Corp (OCBC)'s United Therapeutics position peaked at $382K in Q2 2024.
  • 624 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q3 2024, filed 5 Nov 2024.